We follow the science, to unlock innovation and pursue sustainable answers. We are guided by our commitment to patients, our people and the planet. Our vision is to deliver life-transforming treatments to those in need. We are steadfast in our purpose for better health for people and a brighter future for the world.
概要
We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines
- ウェブサイト
-
https://www.takeda.com/
Takedaの外部リンク
- 業種
- 医薬品製造業
- 会社規模
- 社員 10,001名以上
- 本社
- Tokyo
- 種類
- 上場企業
- 創立
- 1781
- 専門分野
- Pharmaceuticals、Therapeutics、Oncology、Gastroenterology、Vaccines
場所
Takedaの社員
アップデート
-
#News: The European Commission has approved our medicine for the treatment of ADAMTS13 deficiency in children and adults with congenital thrombotic thrombocytopenic purpura (#cTTP). This marks the first and only enzyme replacement therapy in the EU specifically for people with cTTP. Read the announcement: https://lnkd.in/egKYeusB See the Product Information: https://lnkd.in/eEgvzBA9
-
For those with #psoriasis, flare-ups can happen year-round but it’s still important to learn seasonal care. #PsoriasisActionMonth These tips and more can be found via the National Psoriasis Foundation: https://lnkd.in/enmYa_ap Takeda does not have any approved treatment for psoriasis. Please consult your healthcare provider for medical advice.
-
Left unchecked, #CeliacDisease can cause a range of gastrointestinal (GI) and extraintestinal (non-GI) symptoms—that’s why early detection and careful management with a doctor is key. Learn more about our dedication to helping those affected by celiac disease: https://lnkd.in/eNZw9Tbt Takeda does not have any approved treatment for celiac disease. Please consult your healthcare provider for medical advice.
-
We recognize that the well-being of people and the communities we serve are inextricably linked to the health of our planet. Read more about our efforts to actively fostering a healthier planet that benefits more people on page 19 in our annual report: https://lnkd.in/epmujEUR #ClimateChange #ClimateHealth #Sustainability #NetZero
-
By unleashing the power of data, digital and technology, our Plasma-Derived Therapies (PDT) team is creating new paradigms and driving operational excellence — and ultimately, changing more lives worldwide. What makes it better is working on a welcoming team that is always willing to help you grow and learn. To Jennifer Bergman, PDT DD&T Portfolio, Vendor and Financial Management Lead, that’s what leaves the greatest impact. Explore open roles on our PDT team today: https://lnkd.in/eth7qzmJ #CareersInPharma #Hiring
-
Our Global Pathogen Safety lab’s philosophy reflects our company’s long history of taking an innovative approach to transforming patients’ lives. Read more. https://lnkd.in/eVfTa6kh
-
There is a clear connection between #climatechange and people's health. That is why, in the same way that we pursue better health for people, we are committed to protecting the health of our #planet. At one of our sites in Vienna, Austria, we are taking up the challenge of reducing our carbon footprint innovatively. Learn more from our new video which features some of our employees and partners. Learn more here: https://lnkd.in/ekSS3nJZ #Sustainability
-
We are proud to share that we have received a top score of 100 on the Disability Equality Index® (DEI) and have been named a Best Place to Work for Disability Inclusion by Disability:IN for the third year in a row. We will continue with our commitment to inclusivity and our mission to foster a workplace where everyone feels valued and supported. We believe in celebrating differences and continuously improving our disability inclusion practices by enhancing accessibility in the workspace. Learn more about our DE&I commitments: https://lnkd.in/ePdTwCaW #DEI #DisabilityIN
-
Our FY2024 Q1 earnings results demonstrated strong performance in our key Growth & Launch Product portfolio and advancements in our promising late-stage pipeline, underscoring our commitment to putting patients first and delivering life-transforming treatments. Learn more about our results, outlook, pipeline progress and how we are maximizing our existing portfolio to treat more patients: https://lnkd.in/gqqx9UBF Keep up to date with our corporate milestones and how we’re delivering on our commitments to patients, our people and the planet by signing up for our investor newsletter: https://lnkd.in/g-eSYsy6